TODAY’S NEWS
Ouch – more NJ pharma job cuts – Call it the proverbial one-two punch. On Jan. 31, Pfizer expects to chop 400 jobs from Monmouth Junction, where Wyeth maintained research offices. And on Feb. 9, Merck will eliminate 500 jobs from Kenilworth, where Schering-Plough had its headquarters, although it’s not clear which types of jobs will be affected...more
Cephalon‘s jet lag pill not ready for takeoff – For those of you who were unaware, Cephalon is anxiously awaiting FDA approval to sell Nuvigil, a slightly modified form of its Provigil narcolepsy pill, to combat jet-lag disorder. The drugmaker had hoped for a regulatory okay last month, but the agency delayed a decision in order to review data…more. After recent airline news, maybe they should rename it NuVigilant and package it for TSA inspectors…
Simulations. It takes solid expertise and creativity to make great eLearning simulations. And our network has the providers you need. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
PLUS
JUST FOR FUN
———-
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
Connect with Steve Woodruff
Leave a Reply